Cargando…
Evaluating LDL-C control in Indian acute coronary syndrome (ACS) patients- A retrospective real-world study LDL-C control in ACS
BACKGROUND: Low-density lipoprotein-cholesterol (LDL-C) is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD) progression. Although lipid lowering therapies remain the cornerstone of secondary ACSVD prevention, there exists residual dyslipidemia. The current study aimed to...
Autores principales: | Jain, Madhur, Sawant, Rahul, Panchal, Hitanshu, S, Anand, Jena, Anupam, Gupta, Rahul, Kumar, Karthik, Jambunathan, Rajagopal, Modi, Sunil, Mullasari, Ajit, Sinha, Nakul, Shetty, Kimi, Kawatra, Pallavi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523158/ https://www.ncbi.nlm.nih.gov/pubmed/37771607 http://dx.doi.org/10.1016/j.ijcrp.2023.200210 |
Ejemplares similares
-
Should We Intensify Statin Management in ACS Patients with Very Low LDL Cholesterol Levels?
por: Han, Ki Hoon
Publicado: (2019) -
HDL Function and Size in Patients with On-Target LDL Plasma Levels and a First-Onset ACS
por: Cordero, Alberto, et al.
Publicado: (2023) -
Thyristor control of A.C. motors
por: Murphy, John M D
Publicado: (1973) -
High Triglyceride-Glucose Index is Associated with Poor Cardiovascular Outcomes in Nondiabetic Patients with ACS with LDL-C below 1.8 mmol/L
por: Zhang, Yue, et al.
Publicado: (2022) -
Pemafibrate decreases triglycerides and small, dense LDL, but increases LDL-C depending on baseline triglycerides and LDL-C in type 2 diabetes patients with hypertriglyceridemia: an observational study
por: Komiya, Ichiro, et al.
Publicado: (2021)